Skip To Main Content
Yueming Yu on Muck Rack

Yueming Yu

As seen in: Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Yueming Yu’s profile

Articles by Yueming Yu

Correction to “In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer”

|
By Kaili Wang, Chunjing Guo, Xue Dong, Yueming Yu
| dx.doi.org
In the initially published version, Figure 5A is incorrect. The correct figure is provided below. The method description in Section 2.6, should be “at different time points (2, 4, 8, and 12 h). All animal studies were conducted in accordance with the Institutional Animal Care and Use Committee (IACUC) guidelines of Yantai University (Protocol No. YTU20170419) and conducted in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals (8th Edition, 2011).
Open in Who Shared Issue with article?

Supramolecular self-assembly and perfected in vitro/vivo property of 5-fluorouracil and ferulic acid on the strength of double optimized strategy: The first 5-fluorouracial-phenolic acid nutraceutical cocrystal with synergistic antitumor efficacy

|
By Yueming Yu, Yuan-Yuan Niu, Ling-Yang Wang, Yan-Tuan Li
| Royal Society of Chemistry Verified
Supramolecular self-assembly and perfected in vitro/vivo property of 5-fluorouracil and ferulic acid on the strength of double optimized strategy: The first 5-fluorouracial-phenolic acid nutraceutical cocrystal with synergistic antitumor efficacy Yueming Yu, Yuan-Yuan Niu, Ling-Yang Wang, Yan-Tuan Li, Zhi-Yong Wu and Cui-Wei Yan Abstract For highlighting the predominance of phenolic acid nutraceutical ferulic acid (FR) in regulating in vivo/vitro performances of anticancer drug...
Open in Who Shared Issue with article?

In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer

|
By Kaili Wang, Xue Dong, Chunjing Guo, Yueming Yu
| American Chemical Society
Many cancers, such as human breast cancer and lung cancer, easily metastasize to bones, leading to the formation of secondary tumors in advanced stages. On the basis of the CD44-targeted effect of oHA and the bone-targeted effect of ALN, we prepared a reduction-responsive, CD44 receptor-targeting and bone-targeting nanomicelle, called CUR-loaded ALN-oHA-S-S-CUR micelles. In this study, we aimed to evaluate the antitumor activity and bone-targeting ability of CUR-loaded ALN-oHA-S-S-CUR micelles.
Open in Who Shared Issue with article?
Show More